The reason for dopamine D3 receptor’s elevation in early-stage PD may be due to its promotion of T cell activation and induction of neuroinflammation, which could be an underlying factor in the role that dopamine D3 receptor’s activation plays in PD pathogenesis. This evidence concerns the gene DRD3 and Parkinson disease.